Publication | Open Access

An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial

ThrombosisHypertensionVascular DiseaseCardiovascular DiseaseMedicineCrossover Phase 2Hereditary AngioedemaOn-demand TreatmentPharmacotherapyPharmacologyAnticoagulantAtherosclerosisPeripheral Vascular Disease